TABLE 2

Outcomes at 3 and 6 months post-intensive care unit (ICU) discharge for mechanically ventilated COVID-19 survivors and significance of change over time

Outcome3 months6 monthsp-value
Subjects n5050
Days from ICU discharge89 (86–93)174 (113–133)
Days from symptom onset119 (113–183)205 (194–222)
Inspiratory muscle strength
 MIP cmH2O73 (51.5–102)86.5 (67.5–111)0.001
 MIP % predicted70 (60–89)87.6 (70–99)0.001
 MIP <70% predicted24 (48)12 (24)0.001
Diaphragm ultrasound imaging
 Diaphragm thickness mm0.20 (0.16–0.28)0.24 (0.17–0.28)0.051
 Diaphragm thickness <LLN4 (8)1 (2)0.100
 Diaphragm thickening ratio1.54 (1.42–1.72)1.65 (1.52–1.79)0.009
 Diaphragm thickening ratio <LLN0 (0)0 (0)
Functional capacity
 6MWD442.5 (384–537)520 (405–588)0.001
 6MWD % predicted71 (66–82)82 (71.5–90)0.001
 6MWD <70% predicted23 (46)10 (20)0.001
SpO2 pre-test96 (96–98)96 (95–97)0.043
SpO2 immediately post-test95 (93–96)95 (93–97)0.223
 ΔSpO22.5 (1–4)1 (−0.25–4)0.05
 Post-test desaturation (ΔSpO2 ≥4%)14 (28)14 (28)
 Breathlessness Borg score3 (2–4)3 (2–4)0.935
 Lower limb fatigue Borg score1 (0–3)2 (0–3)0.723
Dyspnoea
 mMRC score1 (1–2)1 (0.75–1)0.001
 mMRC score grade0.001
  05 (10)12 (24)
  124 (48)27 (54)
  213 (26)8 (16)
  33 (6)1 (2)
  45 (10)2 (4)
Health-related quality of life
 SGRQ total score20.53 (9.74–30.70)13.05 (3.85–21.38)0.001
 SGRQ symptoms domain0.0 (0.0–15.78)0.0 (0.0–9.21)0.049
 SGRQ activity domain37.75 (18.73–55.58)25.9 (6.07–45.91)0.001
 SGRQ impact domain6.85 (2.42–22.83)4.4 (0.0–12.04)0.001

Data are presented as median (25th–75th percentile) for continuous variables and n (%) for categorical variables. MIP: maximal inspiratory pressure; LLN: lower limit of normality; 6MWD: 6-min walk distance; SpO2: pulse oximeter oxyhaemoglobin saturation; mMRC: modified Medical Research Council; SGRQ: St George's Respiratory Questionnaire. Bold values denote statistical significance p<0.05.